Better Markets has filed an amicus brief urging the Second Circuit to overturn Ripple's 2023 court victory, claiming misapplication of the Howey Test.
Shionogi’s S-892216 is being developed as a pre-exposure prophylaxis (PrEP) drug for Covid-19. Credit: seksan Mongkhonkhamsao ...
The settlement was signed Thursday afternoon, just hours after the former New York City Mayor had been set to testify.